Spreading Depolarization after Traumatic Brain Injury and Subdural Hematoma: A Context-Specific Framework for Recognition and Clinical Interpretation without Electrocorticography.
Oda Kazunori K, Grubb Kristina K, Saluja Rajeet Singh RS, Marcoux Judith J
Spreading depolarization (SD) is a near-complete breakdown of transmembrane ion gradients that propagates through gray matter and imposes substantial metabolic stress. Direct subdural electrocorticography (ECoG) has established SD as a common and prognostically relevant secondary injury process in a subset of patients with severe traumatic brain injury (TBI), whereas a smaller body of literature implicates SD in recurrent transient neurological symptoms after subdural hematoma (SDH), particularly chronic SDH (cSDH) and after hematoma evacuation. These populations should not, however, be treated as a single clinical syndrome. In this narrative review, we distinguish three context-specific evidence domains: (1) directly monitored SD in severe or surgical TBI, (2) SD as a plausible contributor to recurrent stereotyped focal symptoms after cSDH/SDH evacuation, and (3) imaging correlates of prior SD-associated spreading ischemia. We emphasize that routine scalp electroencephalogram (EEG) does not diagnose SD in patients with intact skull, that seizures and SD can coexist, and that cortical-predominant or laminar ischemic injury on magnetic resonance imaging (MRI) can support but cannot establish active SD. We propose a context-specific clinical approach for centers without ECoG that focuses on recognizing when SD should enter the differential, defines what conventional EEG and imaging can and cannot establish, and identifies situations in which direct monitoring may be valuable. Standard physiological optimization remains foundational in severe acute brain injury but is not an SD-specific treatment recommendation. Ketamine can suppress ECoG-confirmed SD, whereas evidence for nimodipine, memantine, topiramate, and other candidate therapies remains context dependent or investigational. Prospective validation is required before unmonitored clinical patterns are used as treatment triggers.